Targeting Skp1, an ubiquitin E3 ligase component found decreased in sporadic Parkinson's disease

Neurodegenerative Diseases

Volumn 10, Issue 1-4, 2012, Pages 220-223

  Mandel, Silvia A ^a   Fishman Jacob, Tali ^a   Youdim, Moussa B H ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Disease model; Dopaminergic markers; SCF E3 complex; Short hairpin RNA lentiviruses; Sporadic Parkinson's disease

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE A1; DOPAMINE TRANSPORTER; F BOX PROTEIN; FBXO2 PROTEIN; LENTIVIRUS VECTOR; S PHASE KINASE ASSOCIATED PROTEIN; S PHASE KINASE ASSOCIATED PROTEIN 1; SHORT HAIRPIN RNA; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; VESICULAR MONOAMINE TRANSPORTER 2;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; DOPAMINERGIC NERVE CELL; DOWN REGULATION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; LETHALITY; LEWY BODY; MESENCEPHALON; NERVE CELL DIFFERENTIATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; SPORADIC PARKINSON DISEASE;

ANIMALS; DOPAMINERGIC NEURONS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PARKINSON DISEASE; PROTEIN-SERINE-THREONINE KINASES; RNA INTERFERENCE; SUBSTANTIA NIGRA;

EID: 84860215666     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000333223     Document Type: Article

References (13)

1. Mandel S, Grunblatt E, Riederer P, Gerlach M, Levites Y, Youdim MB: Neuroprotective strategies in Parkinson's disease: An update on progress. CNS Drugs 2003; 17: 729-762.
2. Dawson TM, Dawson VL: Molecular pathways of neurodegeneration in Parkinson's disease. Science 2003; 302: 819-822.
3. Mandel S, Morelli M, Halperin I, Korczyn AD: Biomarkers for prediction and targeted prevention of Alzheimer's and Parkinson's diseases: evaluation of drug clinical efficacy. EPMA J 2010; 1: 273-292.
4. Grunblatt E, Mandel S, Jacob-Hirsch J, Zeligson S, Amariglo N, Rechavi G, Li J, Ravid R, Roggendorf W, Riederer P, Youdim MB: Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes. J Neural Transm 2004; 111: 1543-1573.
5. Mandel SA, Fishman T, Youdim MB: Gene and protein signatures in sporadic Parkinson's disease and a novel genetic model of PD. Parkinsonism Relat Disord 2007; 13 (suppl 3):S242-S247.
6. Zheng N, Schulman BA, Song L, Miller JJ, Jeffrey PD, Wang P, Chu C, Koepp DM, Elledge SJ, Pagano M, Conaway RC, Conaway JW, Harper JW, Pavletich NP: Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex. Nature 2002; 416: 703-709.
7. Fishman-Jacob T, Reznichenko L, Youdim MB, Mandel SA: A sporadic Parkinson's disease model via silencing of the ubiquitinproteasome/ E3-ligase component, SKP1A. J Biol Chem 2009; 284: 32835-32845.
8. Di Fonzo A, Dekker MC, Montagna P, Baruzzi A, Yonova EH, Correia Guedes L, Szczerbinska A, Zhao T, Dubbel-Hulsman LO, Wouters CH, de Graaff E, Oyen WJ, Simons EJ, Breedveld GJ, Oostra BA, Horstink MW, Bonifati V: FBXO7 mutations cause autosomal recessive, early-onset parkinsonian- pyramidal syndrome. Neurology 2009; 72: 240-245.
9. Chang YF, Cheng CM, Chang LK, Jong YJ, Yuo CY: The F-box protein Fbxo7 interacts with human inhibitor of apoptosis protein cIAP1 and promotes cIAP1 ubiquitination. Biochem Biophys Res Commun 2006; 342: 1022-1026.
10. Nelson RF, Glenn KA, Zhang Y, Wen H, Knutson T, Gouvion CM, Robinson BK, Zhou Z, Yang B, Smith RJ, Paulson HL: Selective cochlear degeneration in mice lacking the F-box protein, Fbx2, a glycoproteinspecific ubiquitin ligase subunit. J Neurosci 2007; 27: 5163-5171.
11. Marx FP, Soehn AS, Berg D, Melle C, Schiesling C, Lang M, Kautzmann S, Strauss KM, Franck T, Engelender S, Pahnke J, Dawson S, von Eggeling F, Schulz JB, Riess O, Kruger R: The proteasomal subunit S6 ATPase is a novel synphilin-1 interacting protein - Implications for Parkinson's disease. FASEB J 2007; 21: 1759-1767.
12. Auluck PK, Chan HY, Trojanowski JQ, Lee VM, Bonini NM: Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. Science 2002; 295: 865-868.
13. Jellinger KA: Prevalence of stroke in Parkinson's disease. Mov Disord 2003; 18: 723-724.